IL155780A0 - Novel method for analysing phenotypic characteristics of human imunodeficiency virus (hiv) - Google Patents

Novel method for analysing phenotypic characteristics of human imunodeficiency virus (hiv)

Info

Publication number
IL155780A0
IL155780A0 IL15578001A IL15578001A IL155780A0 IL 155780 A0 IL155780 A0 IL 155780A0 IL 15578001 A IL15578001 A IL 15578001A IL 15578001 A IL15578001 A IL 15578001A IL 155780 A0 IL155780 A0 IL 155780A0
Authority
IL
Israel
Prior art keywords
analysing
hiv
novel method
phenotypic characteristics
imunodeficiency virus
Prior art date
Application number
IL15578001A
Other languages
English (en)
Original Assignee
Bioalliance Pharma
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0014495A external-priority patent/FR2816634A1/fr
Priority claimed from FR0103970A external-priority patent/FR2816635A1/fr
Application filed by Bioalliance Pharma, Inst Nat Sante Rech Med filed Critical Bioalliance Pharma
Publication of IL155780A0 publication Critical patent/IL155780A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15578001A 2000-11-10 2001-11-09 Novel method for analysing phenotypic characteristics of human imunodeficiency virus (hiv) IL155780A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0014495A FR2816634A1 (fr) 2000-11-10 2000-11-10 Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)
FR0103970A FR2816635A1 (fr) 2000-11-10 2001-03-23 Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)
US09/817,135 US20020123036A1 (en) 2000-11-10 2001-03-27 Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics
PCT/FR2001/003512 WO2002038792A2 (fr) 2000-11-10 2001-11-09 Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine (vih)

Publications (1)

Publication Number Publication Date
IL155780A0 true IL155780A0 (en) 2003-12-23

Family

ID=27248715

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15578001A IL155780A0 (en) 2000-11-10 2001-11-09 Novel method for analysing phenotypic characteristics of human imunodeficiency virus (hiv)

Country Status (7)

Country Link
US (2) US20030207294A1 (de)
EP (1) EP1364071A2 (de)
JP (2) JP2005500003A (de)
AU (2) AU2002223052B2 (de)
CA (1) CA2429073A1 (de)
IL (1) IL155780A0 (de)
WO (1) WO2002038792A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012270A (es) 1999-05-28 2003-06-24 Virco Nv Nuevos perfiles mutacionales en la transcriptasa reversa de vih-1 correlacionadas con resistencia fenotipica a farmacos.
EP1356082A2 (de) 2000-10-20 2003-10-29 Virco Bvba Mutationsprofile bei mit phänotypischer medikamentenresistenz korrelierter hiv-1-reverse-transkriptase
FR2829503B1 (fr) * 2001-03-23 2007-06-01 Bioalliance Pharma Nouvelee methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
FR2829502B1 (fr) * 2001-03-23 2006-01-13 Bioalliance Pharma Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
FR2829501B1 (fr) * 2001-03-23 2006-03-03 Bioalliance Pharma Nouvelle methode d'analyse des caracteristiques phenotypiques des virus de l'immunodeficience humaine(vih)
US7306901B2 (en) * 2001-08-08 2007-12-11 Tibotec Pharmaceuticals, Ltd. Methods and means for assessing HIV envelope inhibitor therapy
WO2003040390A2 (en) 2001-11-08 2003-05-15 Tibotec Pharmaceuticals Ltd. Protease assay for therapeutic drug monitoring
EP1552024A4 (de) * 2002-07-01 2007-04-18 Virologic Inc Zusammensetzungen und verfahren zur bestimmung des replikationsvermögens eines krankheitserregenden virus
US7217506B2 (en) 2002-07-01 2007-05-15 Tibotec Pharmaceuticals, Ltd. Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance
AU2003251732B2 (en) 2002-07-01 2008-09-18 Tibotec Pharmaceuticals Ltd. New mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
WO2008047227A2 (en) * 2006-10-20 2008-04-24 Eurofins Viralliance Inc. Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors
EP1914309A1 (de) * 2006-10-20 2008-04-23 Eurofins Viralliance Inc. Verfahren zur Ermittlung des HIV-1 Tropismus für CCR5 und/oder CXCR4 Co-Rezeptoren und/oder deren Empfindlichkeit gegenüber Eingangs-Inhibitoren
AU2008257703A1 (en) 2007-05-25 2008-12-04 Tibotec Pharmaceuticals New mutational profile in HIV-1 Gag cleavage site correlated with phenotypic drug resistance
WO2014145408A1 (en) * 2013-03-15 2014-09-18 The Johns Hopkins University Clinical methods for determining hiv-1 receptor tropism and cellular reservoirs of hiv-1 replication
WO2020150499A1 (en) * 2019-01-16 2020-07-23 Fred Hutchinson Cancer Research Center Methods to tag and isolate cells infected with the human immunodeficiency virus
CN115287372A (zh) * 2022-04-21 2022-11-04 中国人民解放军军事科学院军事医学研究院 扩增hiv-1 rre全长序列的引物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
WO1999033992A1 (en) * 1997-12-31 1999-07-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Murine intracisternal a particle constitutive transport elements and uses thereof
US6103462A (en) * 1998-05-29 2000-08-15 Institut Pasteur Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
GB9909793D0 (en) * 1999-04-28 1999-06-23 Glaxo Group Ltd Improved assay and reagents therefor

Also Published As

Publication number Publication date
US20040053219A1 (en) 2004-03-18
AU2305202A (en) 2002-05-21
AU2002223052B2 (en) 2007-09-20
EP1364071A2 (de) 2003-11-26
CA2429073A1 (fr) 2002-05-16
WO2002038792A2 (fr) 2002-05-16
WO2002038792A3 (fr) 2003-09-25
US20030207294A1 (en) 2003-11-06
JP2008022861A (ja) 2008-02-07
JP2005500003A (ja) 2005-01-06

Similar Documents

Publication Publication Date Title
IL155780A0 (en) Novel method for analysing phenotypic characteristics of human imunodeficiency virus (hiv)
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
IL150756A0 (en) Novel use of hiv proteins
AU2002223052A1 (en) Novel method for analysing phenotypic characteristics of human immunodeficiency virus (HIV)
EP1432721A4 (de) Verfahren zur herstellung von rebeccamycin und analogen davon
HUP0401451A3 (en) Method for preparation of escitalopram
HUP0400393A3 (en) Method for virus propagation
HUP0402252A3 (en) Method for preparation of escitalopram
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
PL367523A1 (en) Compositions for removing human cerumen
AU2002365442A8 (en) Method of inhibiting pathogenicity of infectious agents
GB0115581D0 (en) Method of mass spectometry
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU5881001A (en) Method of stabilizing preparation
AU2001256675A1 (en) Method of preparing virus vector
HUP0303418A3 (en) Inhibitors of papilloma virus
AU2001270209A1 (en) Hiv-1 vaccines and screening methods therefor
AU2001261260A8 (en) Methods for accelerated desensitization of teeth
ZA200309774B (en) Methods for preparation and use of psorospermin analogs.
TW423552U (en) Improved pedal of scaffold
AU2001278931A1 (en) Process of parallel sample preparation
GB0104993D0 (en) Methods for analysis of RNA
HK1063628A (en) Methods for preparation and use of psorospermin analogs
PL347523A1 (en) Method of obtaining 11alpha-hydroxy-1-dehydrotestosterone
PL342955A1 (en) Method of obtaining 1,4:3,6-dianhydro-d,l-iditole from galactitole